148 related articles for article (PubMed ID: 36460622)
21. HMM-GDAN: Hybrid multi-view and multi-scale graph duplex-attention networks for drug response prediction in cancer.
Liu Y; Tong S; Chen Y
Neural Netw; 2023 Oct; 167():213-222. PubMed ID: 37660670
[TBL] [Abstract][Full Text] [Related]
22. GHNN: Graph Harmonic Neural Networks for semi-supervised graph-level classification.
Ju W; Luo X; Ma Z; Yang J; Deng M; Zhang M
Neural Netw; 2022 Jul; 151():70-79. PubMed ID: 35398673
[TBL] [Abstract][Full Text] [Related]
23. Hi-GeoMVP: a hierarchical geometry-enhanced deep learning model for drug response prediction.
Chen Y; Zhang L
Bioinformatics; 2024 Mar; 40(4):. PubMed ID: 38614131
[TBL] [Abstract][Full Text] [Related]
24. A novel hybrid framework for metabolic pathways prediction based on the graph attention network.
Yang Z; Liu J; Shah HA; Feng J
BMC Bioinformatics; 2022 Sep; 23(Suppl 5):329. PubMed ID: 36171550
[TBL] [Abstract][Full Text] [Related]
25. Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network.
Liu P; Li H; Li S; Leung KS
BMC Bioinformatics; 2019 Jul; 20(1):408. PubMed ID: 31357929
[TBL] [Abstract][Full Text] [Related]
26. Improving drug response prediction based on two-space graph convolution.
Peng W; Chen T; Liu H; Dai W; Yu N; Lan W
Comput Biol Med; 2023 May; 158():106859. PubMed ID: 37023539
[TBL] [Abstract][Full Text] [Related]
27. The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer.
Wang C; Zhang M; Zhao J; Li B; Xiao X; Zhang Y
Comput Biol Med; 2023 Sep; 163():107220. PubMed ID: 37406589
[TBL] [Abstract][Full Text] [Related]
28. Attentional multi-level representation encoding based on convolutional and variance autoencoders for lncRNA-disease association prediction.
Sheng N; Cui H; Zhang T; Xuan P
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444875
[TBL] [Abstract][Full Text] [Related]
29. AttenSyn: An Attention-Based Deep Graph Neural Network for Anticancer Synergistic Drug Combination Prediction.
Wang T; Wang R; Wei L
J Chem Inf Model; 2024 Apr; 64(7):2854-2862. PubMed ID: 37565997
[TBL] [Abstract][Full Text] [Related]
30. Prediction of circRNA-Disease Associations Based on the Combination of Multi-Head Graph Attention Network and Graph Convolutional Network.
Cao R; He C; Wei P; Su Y; Xia J; Zheng C
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883487
[TBL] [Abstract][Full Text] [Related]
31. GAE-LGA: integration of multi-omics data with graph autoencoders to identify lncRNA-PCG associations.
Gao M; Liu S; Qi Y; Guo X; Shang X
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36305456
[TBL] [Abstract][Full Text] [Related]
32. MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning.
Li Y; Guo Z; Gao X; Wang G
Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38070154
[TBL] [Abstract][Full Text] [Related]
33. Graph Convolutional Networks for Drug Response Prediction.
Nguyen T; Nguyen GTT; Nguyen T; Le DH
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(1):146-154. PubMed ID: 33606633
[TBL] [Abstract][Full Text] [Related]
34. Graph Convolutional Autoencoder and Fully-Connected Autoencoder with Attention Mechanism Based Method for Predicting Drug-Disease Associations.
Xuan P; Gao L; Sheng N; Zhang T; Nakaguchi T
IEEE J Biomed Health Inform; 2021 May; 25(5):1793-1804. PubMed ID: 33216722
[TBL] [Abstract][Full Text] [Related]
35. AGNN: Alternating Graph-Regularized Neural Networks to Alleviate Over-Smoothing.
Chen Z; Wu Z; Lin Z; Wang S; Plant C; Guo W
IEEE Trans Neural Netw Learn Syst; 2023 May; PP():. PubMed ID: 37256809
[TBL] [Abstract][Full Text] [Related]
36. Predicting anticancer hyperfoods with graph convolutional networks.
Gonzalez G; Gong S; Laponogov I; Bronstein M; Veselkov K
Hum Genomics; 2021 Jun; 15(1):33. PubMed ID: 34099048
[TBL] [Abstract][Full Text] [Related]
37. CID-GCN: An Effective Graph Convolutional Networks for Chemical-Induced Disease Relation Extraction.
Zeng D; Zhao C; Quan Z
Front Genet; 2021; 12():624307. PubMed ID: 33643385
[TBL] [Abstract][Full Text] [Related]
38. DualGCN: a dual graph convolutional network model to predict cancer drug response.
Ma T; Liu Q; Li H; Zhou M; Jiang R; Zhang X
BMC Bioinformatics; 2022 Apr; 23(Suppl 4):129. PubMed ID: 35428192
[TBL] [Abstract][Full Text] [Related]
39. DeepAEG: a model for predicting cancer drug response based on data enhancement and edge-collaborative update strategies.
Lao C; Zheng P; Chen H; Liu Q; An F; Li Z
BMC Bioinformatics; 2024 Mar; 25(1):105. PubMed ID: 38461284
[TBL] [Abstract][Full Text] [Related]
40. Predicting cell line-specific synergistic drug combinations through a relational graph convolutional network with attention mechanism.
Zhang P; Tu S; Zhang W; Xu L
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36136353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
